Patent application number | Description | Published |
20080200692 | Process For the Synthesis of Organic Compounds - The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II): | 08-21-2008 |
20090137805 | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES - The present invention relates to novel amides and a process for preparing these amides. | 05-28-2009 |
20090209502 | COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION - A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation. | 08-20-2009 |
20100280257 | PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS - The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II): | 11-04-2010 |
20120065174 | COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION - A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation. | 03-15-2012 |
20120226039 | N-Phenyl-2-pyrimidine-amine Derivatives - The present invention relates to novel amides and a process for preparing these amides. | 09-06-2012 |
20150018552 | N-Phenyl-2-pyrimidine-amine Derivatives - The present invention relates to novel amides and a process for preparing these amides. | 01-15-2015 |
20150224194 | Compositions of Glycopyrronium Salt for Inhalation - A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation. | 08-13-2015 |